H
Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 1,603,797. Pennsylvania Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Philadelphia clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Philadelphia storefront.
Diabetic Wound Care That Delivers in Philadelphia, PA for clinics & physicians. Specialized diabetic wound… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of diabetic wound care in Philadelphia: (1) CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. (2) Pennsylvania Part B wound biologics are reviewed by Novitas Solutions under JL, shared with DC, DE, MD, NJ. We help with the second file. We do not pretend to be a Philadelphia storefront.
National Diabetic Wound Care That Delivers notes (how the product actually works)Pennsylvania shares JL with DC, DE, MD, NJ. Florida is the only single-state MAC. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Philadelphia trial. Local outcomes stay with the treating physician. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Use that rate for inventory math, not for ads.
CDC PLACES has no incorporated-place row we could match for Philadelphia. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Pennsylvania compliance risk.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Novitas Solutions LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Philadelphia, PA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Philadelphia is JL geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Pennsylvania Part B wound biologics follow this contractor (siblings: DC, DE, MD, NJ). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 1M+, not a count of orthopedic groups.
No Philadelphia storefront. Joe Bradley is an active practice owner. diabetic wound care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.